334 related articles for article (PubMed ID: 1451948)
1. Role of infiltrating T cells for impaired glucose metabolism in pancreatic islets isolated from non-obese diabetic mice.
Strandell E; Sandler S; Boitard C; Eizirik DL
Diabetologia; 1992 Oct; 35(10):924-31. PubMed ID: 1451948
[TBL] [Abstract][Full Text] [Related]
2. Effects of interleukin-12 in vitro on pancreatic islets isolated from normal rodents and from non-obese diabetic mice.
Sternesjö J; Sandler S
J Endocrinol; 1998 Jul; 158(1):69-75. PubMed ID: 9713328
[TBL] [Abstract][Full Text] [Related]
3. Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line.
Chosich N; Harrison LC
Diabetologia; 1993 Aug; 36(8):716-21. PubMed ID: 8405738
[TBL] [Abstract][Full Text] [Related]
4. Studies on autoimmunity for T-cell-mediated beta-cell destruction. Distinct difference in beta-cell destruction between CD4+ and CD8+ T-cell clones derived from lymphocytes infiltrating the islets of NOD mice.
Nagata M; Yoon JW
Diabetes; 1992 Aug; 41(8):998-1008. PubMed ID: 1628775
[TBL] [Abstract][Full Text] [Related]
5. Prolonged exposure of pancreatic islets isolated from "pre-diabetic" non-obese diabetic mice to a high glucose concentration does not impair beta-cell function.
Eizirik DL; Strandell E; Sandler S
Diabetologia; 1991 Jan; 34(1):6-11. PubMed ID: 2055343
[TBL] [Abstract][Full Text] [Related]
6. Reversal of beta-cell suppression in vitro in pancreatic islets isolated from nonobese diabetic mice during the phase preceding insulin-dependent diabetes mellitus.
Strandell E; Eizirik DL; Sandler S
J Clin Invest; 1990 Jun; 85(6):1944-50. PubMed ID: 2189896
[TBL] [Abstract][Full Text] [Related]
7. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors.
Christianson SW; Shultz LD; Leiter EH
Diabetes; 1993 Jan; 42(1):44-55. PubMed ID: 8093606
[TBL] [Abstract][Full Text] [Related]
8. In vitro xenorecognition of adult pig pancreatic islet cells by splenocytes from nonobese diabetic or non-diabetes-prone mice.
Rivereau AS; You S; Lalain S; Gouin E; Saï P
Transplantation; 1998 Sep; 66(5):633-8. PubMed ID: 9753345
[TBL] [Abstract][Full Text] [Related]
9. In vitro response to interleukin-1 beta and streptozotocin in pancreatic islets isolated from male and female nonobese diabetic mice.
Strandell E; Sandler S
J Endocrinol; 1997 Apr; 153(1):81-6. PubMed ID: 9135572
[TBL] [Abstract][Full Text] [Related]
10. Effect of T-cell receptor V beta-specific monoclonal antibodies on cyclophosphamide-induced diabetes mellitus in non-obese diabetic mice.
Taki T; Yokono K; Amano K; Hatamori N; Hirao Y; Tominaga Y; Maeda S; Kasuga M
Diabetologia; 1993 May; 36(5):391-6. PubMed ID: 8314442
[TBL] [Abstract][Full Text] [Related]
11. Islet amyloid polypeptide (IAPP) secretion from pancreatic islets isolated from non-obese diabetic (NOD) mice.
Karlsson E; Stridsberg M; Sandler S
Regul Pept; 1996 May; 63(1):39-45. PubMed ID: 8795087
[TBL] [Abstract][Full Text] [Related]
12. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E.
Hancock WW; Polanski M; Zhang J; Blogg N; Weiner HL
Am J Pathol; 1995 Nov; 147(5):1193-9. PubMed ID: 7485382
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of TNF-alpha and IFN-gamma mRNA expression in islets and spleen of NOD mice.
Ventura-Oliveira D; Vilella CA; Zanin ME; Castro GM; Moreira Filho DC; Zollner RL
Braz J Med Biol Res; 2002 Nov; 35(11):1347-55. PubMed ID: 12426635
[TBL] [Abstract][Full Text] [Related]
14. B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice.
Noorchashm H; Noorchashm N; Kern J; Rostami SY; Barker CF; Naji A
Diabetes; 1997 Jun; 46(6):941-6. PubMed ID: 9166663
[TBL] [Abstract][Full Text] [Related]
15. Beta-cell destruction in NOD mice correlates with Fas (CD95) expression on beta-cells and proinflammatory cytokine expression in islets.
Suarez-Pinzon W; Sorensen O; Bleackley RC; Elliott JF; Rajotte RV; Rabinovitch A
Diabetes; 1999 Jan; 48(1):21-8. PubMed ID: 9892218
[TBL] [Abstract][Full Text] [Related]
16. Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice.
Drage M; Zaccone P; Phillips JM; Nicoletti F; Dawson J; Andrew Bradley J; Cooke A
Transplantation; 2002 Sep; 74(5):611-9. PubMed ID: 12352875
[TBL] [Abstract][Full Text] [Related]
17. Preserved pulsatile insulin release from prediabetic mouse islets.
Lin JM; Sternesjö J; Sandler S; Bergsten P
Endocrinology; 1999 Sep; 140(9):3999-4004. PubMed ID: 10465269
[TBL] [Abstract][Full Text] [Related]
18. The pathogenicity of islet-infiltrating lymphocytes in the non-obese diabetic (NOD) mouse.
Ablamunits V; Elias D; Cohen IR
Clin Exp Immunol; 1999 Feb; 115(2):260-7. PubMed ID: 9933451
[TBL] [Abstract][Full Text] [Related]
19. Establishment of T-cell lines from infiltrated NOD islets by stimulation of specific T-cell receptor V beta segments.
Maugendre D; Legrand B; Olivi M; Bedossa P; Bach JF; Carnaud C
J Autoimmun; 1993 Aug; 6(4):423-36. PubMed ID: 8105789
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 affects insulin secretion and glucose metabolism of rat pancreatic islets in vitro.
Sandler S; Bendtzen K; Eizirik DL; Welsh M
Endocrinology; 1990 Feb; 126(2):1288-94. PubMed ID: 2404746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
